SCHEMBL7879535

SCHEMBL7879535

CC(=O)SCCCBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10484076 0.92
SCHEMBL12177996 0.90 CYP2C19 (0.43)
SCHEMBL22521141 0.90 CYP2C19 (0.43)
SCHEMBL625045 0.90 CYP2C19 (0.43)
SCHEMBL30504176 0.90 CYP2C19 (0.43)
SCHEMBL19194532 0.90 CYP2C19 (0.43)
SCHEMBL5502050 0.90 CYP2C19 (0.43)
SCHEMBL8427233 0.90 CYP2C19 (0.43)
SCHEMBL2256202 0.83
SCHEMBL7908937 0.83 CYP2C19 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119081100-A FAPi, FAPi intermediate, FAPi modified lipid nanoparticle for encapsulating HSP47 siRNA and application of lipid nanoparticle 华东师范大学 2024-12-06 CN disclosed
US-20240336575-A1 POLYTHIOL COMPOUNDS AND PROCESS FOR PREPARATION THEREOF HENKEL AG & CO KGAA (DE) 2024-10-10 US disclosed
US-20240336740-A1 POLYTHIOL COMPOUNDS AND PROCESS FOR PREPARATION THEREOF HENKEL AG & CO KGAA (DE) 2024-10-10 US disclosed
US-20240327341-A1 POLYTHIOL COMPOUNDS AND PROCESS FOR PREPARATION THEREOF HENKEL AG & CO KGAA (DE) 2024-10-03 US disclosed
EP-4198028-B1 POLYTHIOL COMPOUNDS AND PROCESS FOR PREPARATION THEREOF HENKEL AG & CO KGAA (DE) 2024-07-17 EP disclosed
EP-4198062-B1 POLYTHIOL COMPOUNDS AND PROCESS FOR PREPARATION THEREOF HENKEL AG & CO KGAA (DE) 2024-07-17 EP disclosed
WO-2024054512-A1 AKT1 MODULATORS ALTEROME THERAPEUTICS, INC. (US) 2024-03-14 WO disclosed
US-20230270751-A1 BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION PFIZER INC. 2023-08-31 US disclosed
US-20230270751-A1 BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION PFIZER INC. 2023-08-31 US disclosed
US-20230270751-A1 BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION PFIZER INC. 2023-08-31 US disclosed
WO-2015120206-A1 MAO INHIBITORS AND THEIR CONJUGATES AS THERAPEUTICS FOR THE TREATMENT OF BRAIN CANCER UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2015-08-13 WO disclosed
US-20150209361-A1 MAO Inhibitors and Their Conjugates as Therapeutics For The Treatment of Brain Cancer UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2015-07-30 US disclosed
US-20150209361-A1 MAO Inhibitors and Their Conjugates as Therapeutics For The Treatment of Brain Cancer UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2015-07-30 US disclosed
US-20130039854-A1 MONOAMINE OXIDASE INHIBITORS AND METHODS FOR TREATMENT AND DIAGNOSIS OF PROSTATE CANCER UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2013-02-14 US disclosed
US-20130039854-A1 MONOAMINE OXIDASE INHIBITORS AND METHODS FOR TREATMENT AND DIAGNOSIS OF PROSTATE CANCER UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2013-02-14 US disclosed
WO-2013016580-A2 MONOAMINE OXIDASE INHIBITORS AND METHODS FOR TREATMENT AND DIAGNOSIS OF PROSTATE CANCER UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2013-01-31 WO disclosed
WO-2009097515-A2 [A]-FUSED INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES WYETH (US) 2009-08-06 WO disclosed
US-20090192147-A1 [a]-FUSED INDOLE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES WYETH (US) 2009-07-30 US disclosed
US-4487929-A HYPOTENSIVE AGENTS HOFFMANN-LA ROCHE, INC. (US) 1984-12-11 US disclosed
US-4399136-A Pyrazolopyridazine antihypertensives HOFFMANN-LA ROCHE INC. (US) 1983-08-16 US disclosed